OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Luteolin supplements: All that glitters is not gold
Theoharis C. Theoharides
BioFactors (2020) Vol. 47, Iss. 2, pp. 242-244
Closed Access | Times Cited: 19
Theoharis C. Theoharides
BioFactors (2020) Vol. 47, Iss. 2, pp. 242-244
Closed Access | Times Cited: 19
Showing 19 citing articles:
Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 187
Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 127
Theoharis C. Theoharides
Molecular Neurobiology (2022) Vol. 59, Iss. 3, pp. 1850-1861
Open Access | Times Cited: 127
Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
Chenhao Yao, Shu Dai, Cheng Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115464-115464
Open Access | Times Cited: 41
Chenhao Yao, Shu Dai, Cheng Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115464-115464
Open Access | Times Cited: 41
Application of Luteolin in Neoplasms and Nonneoplastic Diseases
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 22
Katarzyna Rakoczy, Justyna Kaczor, Adam Sołtyk, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15995-15995
Open Access | Times Cited: 22
A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis
Yizi Xie, Chen-Wen Peng, Zuqing Su, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Yizi Xie, Chen-Wen Peng, Zuqing Su, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Alejandro Delgado, Christos Cholevas, Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 207-217
Closed Access | Times Cited: 29
Alejandro Delgado, Christos Cholevas, Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 207-217
Closed Access | Times Cited: 29
Protective effect of luteolin against chemical and natural toxicants by targeting NF‐κB pathway
Sina Mahdiani, Navid Omidkhoda, Shadi Heidari, et al.
BioFactors (2022) Vol. 48, Iss. 4, pp. 744-762
Closed Access | Times Cited: 22
Sina Mahdiani, Navid Omidkhoda, Shadi Heidari, et al.
BioFactors (2022) Vol. 48, Iss. 4, pp. 744-762
Closed Access | Times Cited: 22
Mast cell activation: beyond histamine and tryptase
Theoharis C. Theoharides, Adam Perlman, Assma Twahir, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 639-654
Closed Access | Times Cited: 12
Theoharis C. Theoharides, Adam Perlman, Assma Twahir, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 6, pp. 639-654
Closed Access | Times Cited: 12
Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder
Theoharis C. Theoharides
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 860-860
Open Access | Times Cited: 21
Theoharis C. Theoharides
Journal of Personalized Medicine (2021) Vol. 11, Iss. 9, pp. 860-860
Open Access | Times Cited: 21
Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension
Kexin Song, Qingya Duan, Jiping Ren, et al.
Food & Function (2022) Vol. 13, Iss. 20, pp. 10695-10709
Closed Access | Times Cited: 11
Kexin Song, Qingya Duan, Jiping Ren, et al.
Food & Function (2022) Vol. 13, Iss. 20, pp. 10695-10709
Closed Access | Times Cited: 11
Luteolin: Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology
Kevser Taban, Mert İlhan, İpek Süntar
Springer eBooks (2023), pp. 1-37
Closed Access | Times Cited: 6
Kevser Taban, Mert İlhan, İpek Süntar
Springer eBooks (2023), pp. 1-37
Closed Access | Times Cited: 6
Genetics of COVID ‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review
Maria Tziastoudi, Christos Cholevas, Ioannis Stefanidis, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 11, pp. 1838-1857
Open Access | Times Cited: 8
Maria Tziastoudi, Christos Cholevas, Ioannis Stefanidis, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 11, pp. 1838-1857
Open Access | Times Cited: 8
Luteolin: The wonder flavonoid
Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 139-140
Closed Access | Times Cited: 11
Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 139-140
Closed Access | Times Cited: 11
Platelet activating factor: Have we been missing the forest for the trees?
Theoharis C. Theoharides, Smaragdi Antonopoulou, Constantinos A. Demopoulos
BioFactors (2022) Vol. 48, Iss. 6, pp. 1184-1188
Closed Access | Times Cited: 3
Theoharis C. Theoharides, Smaragdi Antonopoulou, Constantinos A. Demopoulos
BioFactors (2022) Vol. 48, Iss. 6, pp. 1184-1188
Closed Access | Times Cited: 3
A Comprehensive Analytical Approach for Quality Control of Collagen in Food Supplements
Nika Kržišnik, Ema Kurent, Robert Roškar
Marine Drugs (2024) Vol. 22, Iss. 10, pp. 435-435
Open Access
Nika Kržišnik, Ema Kurent, Robert Roškar
Marine Drugs (2024) Vol. 22, Iss. 10, pp. 435-435
Open Access
Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, Olea europaea L., in Long COVID and Other Conditions Involving Cognitive Impairment
Paraskevi Papadopoulou, Alexia Polissidis, Georgia Kythreoti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11040-11040
Open Access
Paraskevi Papadopoulou, Alexia Polissidis, Georgia Kythreoti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11040-11040
Open Access
Flavonoids as Complementary Medicines for Therapy and Prevention of COVID-19: Part I. Experimental and Clinical Applications
Ya. F. Zverev, A. Ya. Rykunova
Applied Biochemistry and Microbiology (2024) Vol. 60, Iss. 8, pp. 1584-1602
Closed Access
Ya. F. Zverev, A. Ya. Rykunova
Applied Biochemistry and Microbiology (2024) Vol. 60, Iss. 8, pp. 1584-1602
Closed Access
Mast Cell Sensitization as a Plausible and Researchable Mechanism for Chemical Intolerance
Claudia S. Miller, Raymond F. Palmer, Tania T. Dempsey, et al.
Research Square (Research Square) (2021)
Open Access
Claudia S. Miller, Raymond F. Palmer, Tania T. Dempsey, et al.
Research Square (Research Square) (2021)
Open Access
